Medicines Company (MDCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,156 | -708,373 | -119,172 | -352,746 | -32,348 |
| Depreciation Amortization | 27,886 | 48,842 | 57,224 | 58,513 | 46,318 |
| Income taxes - deferred | 0 | -89,895 | -23 | -53,292 | -5,565 |
| Accounts receivable | 4,959 | 9,180 | 30,144 | 103,100 | -54,739 |
| Accounts payable and accrued liabilities | -9,514 | -17,222 | -7,398 | 16,362 | -6,866 |
| Other Working Capital | -43,307 | -43,430 | -40,494 | -64,608 | -26,828 |
| Other Operating Activity | -118,663 | 432,610 | -243,590 | 94,706 | 147,342 |
| Operating Cash Flow | $-261,795 | $-368,288 | $-323,309 | $-197,965 | $67,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 12,665 | -4,525 | -2,176 | -2,305 | -7,289 |
| Net Acquisitions | 166,383 | N/A | 437,875 | -28,397 | -58,934 |
| Purchase Of Investment | 0 | -131,560 | 0 | N/A | -3,625 |
| Sale Of Investment | 0 | 131,535 | 0 | 19,773 | 0 |
| Purchase Sale Intangibles | 0 | 0 | -10,000 | -112,617 | -15,000 |
| Other Investing Activity | 0 | 0 | -10,000 | -112,582 | -14,908 |
| Investing Cash Flow | $179,048 | $-4,550 | $425,699 | $-123,511 | $-84,756 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 163,000 | 0 | 502,959 | 400,000 | 0 |
| Debt Repayment | 0 | -55,000 | -357,156 | N/A | 0 |
| Common Stock Issued | 15,608 | 48,619 | -54,098 | 95,198 | 17,343 |
| Other Financing Activity | -5,975 | -10,690 | -21,129 | -170,370 | -8,510 |
| Financing Cash Flow | $172,633 | $-17,071 | $70,576 | $324,828 | $8,833 |
| Exchange Rate Effect | -1,766 | -58 | -700 | -920 | 2,623 |
| Beginning Cash Position | 156,900 | 546,867 | 374,601 | 370,741 | 376,727 |
| End Cash Position | 245,020 | 156,900 | 546,867 | 373,173 | 370,741 |
| Net Cash Flow | $88,120 | $-389,967 | $172,266 | $2,432 | $-5,986 |
| Free Cash Flow | |||||
| Operating Cash Flow | -261,795 | -368,288 | -323,309 | -197,965 | 67,314 |
| Capital Expenditure | -7 | -4,525 | -2,176 | -2,555 | -7,289 |
| Free Cash Flow | -261,802 | -372,813 | -325,485 | -200,520 | 60,025 |